Natural compounds efficacy in Ophthalmic Diseases: A new twist impacting ferroptosis

Biomed Pharmacother. 2024 Mar:172:116230. doi: 10.1016/j.biopha.2024.116230. Epub 2024 Feb 12.

Abstract

Ferroptosis, a distinct form of cell death, is characterized by the iron-mediated oxidation of lipids and is finely controlled by multiple cellular metabolic pathways. These pathways encompass redox balance, iron regulation, mitochondrial function, as well as amino acid, lipid, and sugar metabolism. Additionally, various disease-related signaling pathways also play a role in the regulation of ferroptosis. In recent years, with the introduction of the concept of ferroptosis and the deepening of research on its mechanism, ferroptosis is closely related to various biological conditions of eye diseases, including eye organ development, aging, immunity, and cancer. This article reviews the development of the concept of ferroptosis, the mechanism of ferroptosis, and its latest research progress in ophthalmic diseases and reviews the research on ferroptosis in ocular diseases within the framework of metabolism, active oxygen biology, and iron biology. Key regulators and mechanisms of ferroptosis in ocular diseases introduce important concepts and major open questions in the field of ferroptosis and related natural compounds. It is hoped that in future research, further breakthroughs will be made in the regulation mechanism of ferroptosis and the use of ferroptosis to promote the treatment of eye diseases. At the same time, natural compounds may be the direction of new drug development for the potential treatment of ferroptosis in the future. Open up a new way for clinical ophthalmologists to research and prevent diseases.

Keywords: Cell death; Eye diseases; Ferroptosis; Mechanism; Natural compounds; Pathways.

Publication types

  • Review

MeSH terms

  • Eye
  • Eye Diseases* / drug therapy
  • Ferroptosis*
  • Humans
  • Iron

Substances

  • Iron